REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 28
08/03/2016 12:10
- Part 28: For the preceding part double click ID:nRSH4027RA
commitment and motivation, is key to the successful delivery of our
business objectives.
Supply chain and business execution risks Difficulties and delays in the Impact Manufacturing, forecasting, distribution and sales difficulties may result in product shortages and significant delays, which may lead to lost Product Sales and materially adversely affect our business, financial condition or results of operations. Impact
manufacturing, distribution and sale of our products We may experience
difficulties and delays in manufacturing our products, such as:> Supply
shortages associated with gaps between forecasted and actual demand for
products.> Supply chain disruptions, including those due to natural or
man-made disasters at one of our facilities or at a critical supplier or
vendor.> Delays related to the construction of new facilities or the
expansion of existing facilities, including those intended to support
future demand for our products.> Inability to supply products due to a
- More to follow, for following part double click ID:nRSH4027RCRecent news on AstraZeneca
See all newsRCS - LHH - LHH, EZRA's AI Leadership Transformation Program
AnnouncementREG - AstraZeneca PLC - Baxdrostat met primary endpoint in Bax24 Ph3 trial
AnnouncementREG - AstraZeneca PLC - Datroway improved OS and PFS in TROPION-Breast02
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Enhertu improved IDFS in early BC in DB-05
Announcement